Tim A Kanters1, Claudia Wolff2, David Boyson3, Claude Kouakam4, Trang Dinh5, Leona Hakkaart6, Maureen P M H Rutten-Van Mölken6. 1. Institute for Medical Technology Assessment, Health Policy & Management, Erasmus University Rotterdam, PO Box 1738, Rotterdam 3000 DR, The Netherlands kanters@bmg.eur.nl. 2. Department of Health Economics and Reimbursement, Medtronic, Route du Molliau 31, Tolochenaz 1131, Switzerland. 3. Cardiac Catheter Suite, Queen Elizabeth the Queen Mother Hospital, Kent CT9 4AN, UK. 4. Hôpital Cardiologique, Centre Hospitalier Régional Universitaire de Lille, 2 Avenue Oscar Lambret, Lille 59000, France. 5. Department of Cardiology, Maastricht University Medical Centre, PO Box 5800, Maastricht 6202 AZ, The Netherlands. 6. Institute for Medical Technology Assessment, Health Policy & Management, Erasmus University Rotterdam, PO Box 1738, Rotterdam 3000 DR, The Netherlands.
Abstract
AIMS: Implantable cardiac monitors (ICMs) are used for long-term heart rhythm monitoring, e.g. to diagnose unexplained syncope or for detection of suspected atrial and ventricular arrhythmias. The newest ICM, Reveal LINQ™ (Medtronic Inc.), is miniaturized and inserted with a specific insertion tool kit. The procedure is therefore minimally invasive and can be moved from catheterization laboratory (cath lab) to a less resource intensive setting. This study aims to assess the change in procedure costs when performed outside the cath lab. METHODS AND RESULTS: A bottom-up costing methodology was used. Data were collected from interviews with physicians, cath lab managers, and financial controllers. Hospitals in the Netherlands, France, and the UK were included in this study. The cost comparison of a Reveal XT implantation in a cath lab setting vs. a Reveal LINQ insertion outside a cath lab resulted in an estimated reduction of €662 for the UK, €682 for the Netherlands, and €781 for France. These cost savings were primarily realized through fewer staff, less equipment, and overhead costs. The net effect on savings depends on the price differential between these two technologies. The patient care pathway can be improved due to the possibility to move the procedure out of the cath lab. CONCLUSION: Inserting the miniaturized version of the ICM is simpler and faster, and the procedure can take place outside the cath lab in a less resource intensive environment. Hospitals save resources when the higher price of the Reveal LINQ does not outweigh these savings. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Implantable cardiac monitors (ICMs) are used for long-term heart rhythm monitoring, e.g. to diagnose unexplained syncope or for detection of suspected atrial and ventricular arrhythmias. The newest ICM, Reveal LINQ™ (Medtronic Inc.), is miniaturized and inserted with a specific insertion tool kit. The procedure is therefore minimally invasive and can be moved from catheterization laboratory (cath lab) to a less resource intensive setting. This study aims to assess the change in procedure costs when performed outside the cath lab. METHODS AND RESULTS: A bottom-up costing methodology was used. Data were collected from interviews with physicians, cath lab managers, and financial controllers. Hospitals in the Netherlands, France, and the UK were included in this study. The cost comparison of a Reveal XT implantation in a cath lab setting vs. a Reveal LINQ insertion outside a cath lab resulted in an estimated reduction of €662 for the UK, €682 for the Netherlands, and €781 for France. These cost savings were primarily realized through fewer staff, less equipment, and overhead costs. The net effect on savings depends on the price differential between these two technologies. The patient care pathway can be improved due to the possibility to move the procedure out of the cath lab. CONCLUSION: Inserting the miniaturized version of the ICM is simpler and faster, and the procedure can take place outside the cath lab in a less resource intensive environment. Hospitals save resources when the higher price of the Reveal LINQ does not outweigh these savings. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Jan Steffel; David Jay Wright; Harald Schäfer; Tabinda Rashid-Fadel; Thorsten Lewalter Journal: Europace Date: 2017-10-01 Impact factor: 5.214
Authors: Prashanthan Sanders; Christopher Piorkowski; Johannes A Kragten; Grahame K Goode; Satish R Raj; Trang Dinh; M Rizwan Sohail; Rishi Anand; Angel Moya-Mitjans; Noreli Franco; Kurt Stromberg; John D Rogers Journal: BMC Cardiovasc Disord Date: 2019-05-31 Impact factor: 2.298
Authors: Roshan D'Souza; Elizabeth Thomas; Scott Macicek; Peter Aziz; Jill K Shivapour; Christopher Snyder Journal: J Innov Card Rhythm Manag Date: 2017-01-15
Authors: Dustin Nash; Hannah Katcoff; Jennifer Faerber; V Ramesh Iyer; Maully J Shah; Michael L O'Byrne; Christopher Janson Journal: J Am Heart Assoc Date: 2022-08-05 Impact factor: 6.106
Authors: Roderick W Treskes; Willem Gielen; Marieke J Wermer; Robert W Grauss; Anouk P van Alem; Reza Alizadeh Dehnavi; Charles J Kirchhof; Enno T van der Velde; Arie C Maan; Ron Wolterbeek; Onno M Overbeek; Martin J Schalij; Serge A Trines Journal: Trials Date: 2017-08-29 Impact factor: 2.279